Gilead Sciences and MSD's once-weekly oral medicine for HIV has been shown to achieve high rates of viral load suppression in ...

However, while access to this information has never been easier, trust in these resources grows increasingly fragile. Faced ...

Kaken Pharmaceutical has revealed the phase 3 results that supported its recent marketing application for serabelisib in ...

Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in ...

Faced with the prospect of running out of cash, Jasper Therapeutics has merged with Kira Pharma to create a larger, ...

Jonathan Reynolds will lead the new combined Department for Business, Innovation, Science and Trade (DBIST). In the midst of ...

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh spoke with Kelly Gold, CFO of CAMP4 Therapeutics, ...

Leela Barham looked at what had happened a year after the NHS 10-Year Plan, released in July 2025, included the commitment to ...

The intense rivalry between Novo Nordisk and Eli Lilly in the market for GLP-1 agonist-based therapies for obesity and type 2 ...

Despite ongoing advancements in genomics, artificial intelligence, and precision medicine, clinical trial success rates have ...

Novartis saw its sales grow 3% in the second quarter, returning to growth after a 1% fall in the first quarter caused by ...

In what is thought to be South Korea's largest biopharma acquisition to date, Samsung Biologics has agreed to buy PolyPeptide ...